Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma by Xu Yang, Feiqing Wang, Feiqing Wang, Xiaoshuang Yuan, Bo Yang, Juan Chen, Jinyang Cheng, Guangyang Liu, Dongxin Tang, Xiao Xu, Sanbin Wang, Zhixu He, Yang Liu, Yanju Li

Get full text

Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies by Xiaoshuang Yuan, Feiqing Wang, Feiqing Wang, Peng Zhao, Bo Yang, Xu Yang, Ting Tian, Bingbing Li, Guangyang Liu, Sanbin Wang, Dongxin Tang, Zhixu He, Yanju Li, Yang Liu

Get full text

Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia by Chike Zhang, Yang Liu, Xiaoshuang Yuan, Xu Yang, Bo Yang, Yi Huang, Feiqing Wang, Zhixu He, Yanju Li

Get full text

Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells by Yang Liu, Xiaoshuang Yuan, Xu Yang, Bo Yang, Guangyang Liu, Xiao Xu, Sanbin Wang, Zhixu He, Feiqing Wang, Yanju Li

Get full text

Efficacy of maintenance or consolidation therapy for multiple myeloma based on proteasome inhibitors: a meta-analysis by Dan Wu, Feiqing Wang, Xu Yang, Bo Yang, Juan Chen, Jinyang Cheng, Bo Wei, Xiaoshuang Yuan, Tingting Tian, Zhenhua Liu, Zhixu He, Yang Liu, Yanju Li

Get full text